Funding

Nutrium Raises $12M Funding In Series A Round

Sep 17, 2025 | By Kailee Rainse

Nutrium, an all-in-one corporate nutrition platform that enables millions of patients worldwide to create personalized meal plans, track progress, manage chronic conditions, maintain weight and live healthier lives, has raised $12 million in Series A funding.

SUMMARY

  • Nutrium, an all-in-one corporate nutrition platform that enables millions of patients worldwide to create personalized meal plans, track progress, manage chronic conditions, maintain weight and live healthier lives, has raised $12 million in Series A funding.

The round was led by Vesalius Biocapital, with participation from Lince Capital, Indico Capital Partners, and Beta Capital.

Already connecting patients to over 350,000 registered dietitians across 90+ countries, Nutrium plans to use the funding to strengthen its global presence and expand its leadership in the corporate nutrition market.

The funding comes at a critical time, as rising healthcare costs from obesity and increasing demand for GLP-1 medications highlight the need for sustainable, expert-led, non-pharmaceutical wellness solutions that deliver better health outcomes for employers and executives.

Read Also - Genoskin Secures $8.7M To Expand Human Skin Models As Sustainable Alternative To Animal Testing

"Nutrition has become a business priority for companies navigating the challenges of obesity and the rapid adoption of GLP-1 treatments " said André Santos CEO and co-founder of Nutrium. "With this funding, we're ready to expand our reach, strengthen our expert network, and deliver even greater outcomes for our clients and their people worldwide."

Nutrium Care, the company’s clinically backed corporate nutrition benefit, delivers measurable health and financial outcomes that help curb rising corporate healthcare costs. On average, partners see triple their investment, with a 5% reduction in employee weight within four months, lower prescription medication use, and higher productivity. The program costs far less than GLP-1 medications while achieving superior retention and adherence. Nutrium’s remarkable 400% revenue growth last year further attracted its latest investors.

"At Vesalius, we are increasingly aware of the challenges associated with obesity and the need for better nutrition care, which is often overlooked as a key solution for such chronic conditions. We believe that Nutrium will be the solution of choice for employers and individuals that would like to improve their overall health." said Qasim Al-Zawawi, Principal at Vesalius Biocapital. "We are impressed by the growth and achievements accomplished by Nutrium, and are thrilled to be leading the Series A, supporting the Nutrium team in their goal of making the world healthier."

Stephan de Moraes, Managing General Partner at the independent venture capital fund manager, Indico Capital Partners, also shared his enthusiasm about the funding round and the company's promise. "Since the start, the team at Nutrium had a clear vision about the key role that nutrition would play in health and wellbeing. We have been fortunate to back that ambition and help the team find a path to fulfill the promise of wellbeing, a key component of longevity, which is a huge and rapidly expanding market."

Building on its success with global brands like Wellhub, Adidas, Vodafone, and Talkspace, Nutrium aims to expand its U.S. operations and form strategic partnerships with health plans and consultants to accelerate the delivery of corporate nutrition care.

About Nutrium

Founded in 2015 in Portugal Nutrium revolutionizes corporate health with Nutrium Care, a comprehensive nutrition program offering personalized dietitian support, digital coaching, and measurable outcomes. Backed by the world’s largest dietitian network, Nutrium has enhanced millions of lives, making healthy eating practical, personalized, and evidence-based for employees worldwide.

Recommended Stories for You